表紙:白血病治療薬の世界市場の分析 (2022年)
市場調査レポート
商品コード
1107233

白血病治療薬の世界市場の分析 (2022年)

Leukemia Therapeutics Global Market Report 2022

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
白血病治療薬の世界市場の分析 (2022年)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

白血病治療薬の世界市場は、2021年の138億8,000万米ドルから2022年には152億7,000万米ドルへ、10.07%のCAGRで成長すると予測されます。白血病治療薬市場は、2026年には207億7,000万米ドルに達し、7.99%のCAGRで成長すると予測されます。

2021年の白血病治療薬市場では、北米が最大の地域となりました。アジア太平洋は、予測期間中に最も成長する地域となる見込みです。

白血病の有病率の上昇は、白血病治療薬市場の成長を促進しています。また、世界中の白血病患者が医療を受けやすくなり、治療法の選択肢が増えたことが、白血病治療薬の需要増に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 白血病治療薬市場の特徴

第3章 白血病治療薬市場の傾向と戦略

第4章 白血病治療薬市場:新型コロナウイルス感染症 (COVID-19) の影響

第5章 白血病治療薬市場:市場規模・成長率

  • 過去の市場 (単位:10億米ドル、2016年~2021年)
    • 市場促進要因
    • 市場抑制要因
  • 市場の予測 (単位:10億米ドル、2021年~2026年、2031年)
    • 市場促進要因
    • 市場抑制要因

第6章 白血病治療薬市場の内訳

  • 治療薬の種類別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
    • 化学療法
    • 免疫療法
    • 標的療法
    • その他の治療
  • 白血病の種類別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
    • 急性リンパ性白血病
    • 急性骨髄性白血病
    • 慢性リンパ性白血病
    • 慢性骨髄性白血病
    • 他の種類の白血病
  • 分子の種類別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
    • 小分子
    • 生物製剤
  • エンドユーザー別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
    • 病院
    • 在宅医療
    • 専門クリニック
    • その他のエンドユーザー

第7章 白血病治療薬市場:地域別・国別分析

  • 地域別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
  • 国別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)

第8章 アジア太平洋の白血病治療薬市場

  • 市場概要
  • 地域情報
  • 治療薬の種類別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
  • エンドユーザー別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)

第9章 中国の白血病治療薬市場

第10章 インドの白血病治療薬市場

第11章 日本の白血病治療薬市場

第12章 オーストラリアの白血病治療薬市場

第13章 インドネシアの白血病治療薬市場

第14章 韓国の白血病治療薬市場

第15章 西欧の白血病治療薬市場

第16章 英国の白血病治療薬市場

第17章 ドイツの白血病治療薬市場

第18章 フランスの白血病治療薬市場

第19章 東欧の白血病治療薬市場

第20章 ロシアの白血病治療薬市場

第21章 北米の白血病治療薬市場

第22章 米国の白血病治療薬市場

第23章 南米の白血病治療薬市場

第24章 ブラジルの白血病治療薬市場

第25章 中東の白血病治療薬市場

第26章 アフリカの白血病治療薬市場

第27章 白血病治療薬市場:競合情勢と企業プロファイル

  • 白血病治療薬市場:競合情勢
  • 白血病治療薬市場:企業プロファイル
    • Novartis International AG
    • AbbVie
    • Bristol Myers Squibb
    • F. Hoffmann-La Roche AG
    • Sanofi S.A.

第28章 白血病治療薬市場における主要な企業合併・買収 (M&A)

第29章 白血病治療薬市場:将来展望と潜在力の分析

第30章 付録

目次
Product Code: h1917

“Leukemia Therapeutics Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global leukemia therapeutics market.

This report focuses on leukemia therapeutics market which is experiencing strong growth. The report gives a guide to the leukemia therapeutics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the leukemia therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Leukemia Therapeutics market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider leukemia therapeutics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The leukemia therapeutics market section of the report gives context. It compares the leukemia therapeutics market with other segments of the leukemia therapeutics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, leukemia therapeutics indicators comparison.

Scope

Markets Covered:

  • 1) By Treatment Type: Chemotherapy; Immunotherapy; Targeted Therapy; Other Treatments
  • 2) By Type Of Leukemia: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Chronic Myeloid Leukemia; Other Type Of Leukemia
  • 3) By Molecule Type: Small Molecules; Biologics
  • 4) By End-Users : Hospitals; Homecare; Specialty Clinics; Other End-Users
  • Companies Mentioned: Novartis International AG; AbbVie; Bristol Myers Squibb; F. Hoffmann-La Roche AG; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary

Major players in the leukemia therapeutics market are: Novartis International AG, AbbVie, Bristol Myers Squibb, F. Hoffmann-La Roche AG, Sanofi S.A., Pfizer Inc., Amgen Inc., Takeda Pharmaceutical, Celgene Corporation, GlaxoSmithKline plc, Exelixis Inc., MorphoSys AG, Otsuka Holdings Company Ltd., and Lupin Ltd.

The global leukemia therapeutics market is expected to grow from $13.88 billion in 2021 to $15.27 billion in 2022 at a compound annual growth rate (CAGR) of 10.07%. The leukemia therapeutics market is expected to reach $20.77 billion in 2026 at a CAGR of 7.99%.

The leukemia therapeutics market consists of sales of the leukemia therapeutics by entities (organizations, sole traders, and partnerships) that are used for the treatment of leukemia. Leukemia is a type of blood cancer that starts in the bone marrow and proceeds to uncontrolled blood cell growth. The type treatment for leukemia depends on various factors such as age, overall health, type of leukemia, its current condition within the body and others.

The main treatment types in leukemia therapeutics are chemotherapy, immunotherapy, targeted therapy, and other treatments. Immunotherapy is a method of leukemia treatment that stimulates the body's immune system to recognize and eliminate malignant cells. These are used to treat acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, and other type of leukemia using small molecules and biologics. The various end users of leukemia therapeutics are hospitals, homecare, specialty clinics, and other end-users.

North America was the largest region in the leukemia therapeutics market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukemia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The leukemia therapeutics market research report is one of a series of new reports from The Business Research Company that provides leukemia therapeutics market statistics, including leukemia therapeutics industry global market size, regional shares, competitors with a leukemia therapeutics market share, detailed leukemia therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the leukemia therapeutics industry. This leukemia therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rising prevalence of leukemia is driving the growth of the leukemia therapeutics market. Leukemia is a type of blood cancer that starts in the bone marrow and proceeds to uncontrolled blood cell growth. The increased accessibility of medical treatment to leukemia patients across the globe and the growing availability of treatment options have contributed to increased demand for leukemia therapeutics. For instance, according to the National Cancer Institute, the number of new leukemia cases in the United States increased from 60,530 cases in 2020 to 61,090 cases in 2021. Therefore, the rising prevalence of leukemia is contributing to the growth of the leukemia therapeutics market.

Combination therapies is new trend gaining popularity in the leukemia therapeutics market. In combination therapies, two or more modalities are tested in combinations with other immunotherapies or targeted therapies that promise to deliver long-term survival benefits that may be unavailable with current approaches. For instance, in September 2021, Dana-Farber Cancer Institute, a US-based cancer treatment, and research institute's clinical research team reported that a combination of three molecularly targeted drugs including an inhibitor of BCL-2 (venetoclax), a second-generation inhibitor of BTK (acalabrutinib), and a CD20 inhibitor (obinutuzumab) are effective against chronic lymphocytic leukemia (CLL).

In November 2021, Pfizer Inc., a US-based pharmaceutical company acquired Trillium Therapeutics for approximately $2.22 billion. With this acquisition, Pfizer aims to boost its's oncology portfolio with the addition of next-generation immuno-therapies of Trillium. Trillium Therapeutics is a Canada-based clinical-stage immuno-oncology company developing therapies for the treatment of cancer.

The countries covered in the leukemia therapeutics market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Table of Contents

1. Executive Summary

2. Leukemia Therapeutics Market Characteristics

3. Leukemia Therapeutics Market Trends And Strategies

4. Impact Of COVID-19 On Leukemia Therapeutics

5. Leukemia Therapeutics Market Size And Growth

  • 5.1. Global Leukemia Therapeutics Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Leukemia Therapeutics Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Leukemia Therapeutics Market Segmentation

  • 6.1. Global Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Other Treatments
  • 6.2. Global Leukemia Therapeutics Market, Segmentation By Type Of Leukemia, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Other Type Of Leukemias
  • 6.3. Global Leukemia Therapeutics Market, Segmentation By Molecule Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Small Molecules
  • Biologics
  • 6.4. Global Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End-Users

7. Leukemia Therapeutics Market Regional And Country Analysis

  • 7.1. Global Leukemia Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Leukemia Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Leukemia Therapeutics Market

  • 8.1. Asia-Pacific Leukemia Therapeutics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 8.3. Asia-Pacific Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Leukemia Therapeutics Market

  • 9.1. China Leukemia Therapeutics Market Overview
  • 9.2. China Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
  • 9.3. China Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Leukemia Therapeutics Market

  • 10.1. India Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 10.2. India Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Leukemia Therapeutics Market

  • 11.1. Japan Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 11.2. Japan Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Leukemia Therapeutics Market

  • 12.1. Australia Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 12.2. Australia Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Leukemia Therapeutics Market

  • 13.1. Indonesia Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 13.2. Indonesia Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Leukemia Therapeutics Market

  • 14.1. South Korea Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 14.2. South Korea Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Leukemia Therapeutics Market

  • 15.1. Western Europe Leukemia Therapeutics Market Overview
  • 15.2. Western Europe Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 15.3. Western Europe Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Leukemia Therapeutics Market

  • 16.1. UK Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 16.2. UK Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Leukemia Therapeutics Market

  • 17.1. Germany Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 17.2. Germany Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Leukemia Therapeutics Market

  • 18.1. France Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 18.2. France Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Leukemia Therapeutics Market

  • 19.1. Eastern Europe Leukemia Therapeutics Market Overview
  • 19.2. Eastern Europe Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 19.3. Eastern Europe Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Leukemia Therapeutics Market

  • 20.1. Russia Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 20.2. Russia Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Leukemia Therapeutics Market

  • 21.1. North America Leukemia Therapeutics Market Overview
  • 21.2. North America Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 21.3. North America Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Leukemia Therapeutics Market

  • 22.1. USA Leukemia Therapeutics Market Overview
  • 22.2. USA Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 22.3. USA Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Leukemia Therapeutics Market

  • 23.1. South America Leukemia Therapeutics Market Overview
  • 23.2. South America Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 23.3. South America Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Leukemia Therapeutics Market

  • 24.1. Brazil Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 24.2. Brazil Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Leukemia Therapeutics Market

  • 25.1. Middle East Leukemia Therapeutics Market Overview
  • 25.2. Middle East Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 25.3. Middle East Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Leukemia Therapeutics Market

  • 26.1. Africa Leukemia Therapeutics Market Overview
  • 26.2. Africa Leukemia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 26.3. Africa Leukemia Therapeutics Market, Segmentation By End-Users , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Leukemia Therapeutics Market Competitive Landscape And Company Profiles

  • 27.1. Leukemia Therapeutics Market Competitive Landscape
  • 27.2. Leukemia Therapeutics Market Company Profiles
    • 27.2.1. Novartis International AG
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. AbbVie
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Bristol Myers Squibb
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. F. Hoffmann-La Roche AG
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Sanofi S.A.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Leukemia Therapeutics Market

29. Leukemia Therapeutics Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer